Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Argon laser trabeculoplasty: long-term results

R Lotti1, C E Traverso, U Murialdo

  • 1University Eye Clinic, Genova, Italy.

Ophthalmic Surgery
|March 1, 1995
PubMed
Summary

Argon laser trabeculoplasty (ALT) shows high initial success in treating primary open-angle glaucoma. However, its effectiveness decreases over time, with long-term success rates declining significantly after 10 years.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vivo Confocal Microscopy Characterization of Candida parapsilosis Keratitis.

Eye & contact lens·2024
Same author

Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

Razumab -- the role of biosimilars for the treatment of retinal diseases.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

An update on ripasudil for the treatment of glaucoma and ocular hypertension.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

An update on conbercept to treat wet age-related macular degeneration.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension.

Drugs of today (Barcelona, Spain : 1998)·2019

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Interventions

Background:

  • Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
  • Argon laser trabeculoplasty (ALT) is a common surgical option for managing POAG.
  • Long-term efficacy data for ALT is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate the long-term success of argon laser trabeculoplasty (ALT) in patients with primary open-angle glaucoma (POAG).
  • To determine the cumulative success rates of ALT over an 11-year follow-up period.

Main Methods:

  • A retrospective analysis of 237 eyes from 175 patients with POAG treated with ALT.
  • Kaplan-Meier life-table analysis was used to calculate cumulative success rates.
  • Success was defined as avoiding glaucoma surgery or maintaining intraocular pressure (IOP) below 22 mm Hg.

Main Results:

  • Initial success rates were high, with 78% at 1 year.
  • Success rates demonstrated a time-dependent decline: 71% at 3 years, 61% at 5 years, and 40% at 10.5 years.
  • The study confirms previous findings on the initial efficacy and subsequent decline of ALT.

Conclusions:

  • Argon laser trabeculoplasty (ALT) provides significant initial IOP reduction and glaucoma control.
  • The efficacy of ALT diminishes over time, necessitating careful long-term monitoring and potential retreatment or alternative surgical interventions.
  • ALT remains a valuable option for initial glaucoma management, but its long-term durability requires consideration.

Related Experiment Videos